|
1
|
Murray HW and Tuazon C: Atypical
pneumonias. Med Clin North Am. 64:507–527. 1980.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Martin RE and Bates JH: Atypical
pneumonia. Infect Dis Clin North Am. 5:585–601. 1991.PubMed/NCBI
|
|
3
|
Blasi F: Atypical pathogens and
respiratory tract infections. Eur Respir J. 24:171–181.
2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Garin N, Marti C, Skali Lami A and Prendki
V: Atypical pathogens in adult community-acquired pneumonia and
implications for empiric antibiotic treatment: A narrative review.
Microorganisms. 10(2326)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gong C, Zhang T, Luo M, Li A, Dong M, Li
M, Wang Y and Huang F: Distribution of the atypical pathogens of
community-acquired pneumonia to disease severity. J Thorac Dis.
10:5991–6001. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cunha BA: The atypical pneumonias:
Clinical diagnosis and importance. Clin Microbiol Infect. 12 (Suppl
3):S12–S24. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cheng YJ, Lin KY, Chen CC, Huang YL, Liu
CE and Li SY: Zoonotic atypical pneumonia due to Chlamydophila
psittaci: First reported psittacosis case in Taiwan. J Formos Med
Assoc. 112:430–433. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lynch JP III and Clark NM: Pneumonia |
Atypical. Encyclopedia of Respiratory Medicine. 2006:410–417.
2006.
|
|
9
|
Woodhead MA and Macfarlane JT: Comparative
clinical and laboratory features of legionella with pneumococcal
and mycoplasma pneumonias. Br J Dis Chest. 81:133–139.
1987.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sopena N, Sabrià-Leal M, Pedro-Botet ML,
Padilla E, Dominguez J, Morera J and Tudela P: Comparative study of
the clinical presentation of Legionella pneumonia and other
community-acquired pneumonias. Chest. 113:1195–1200.
1998.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mulazimoglu L and Yu VL: Can Legionnaires
disease be diagnosed by clinical criteria? A critical review.
Chest. 120:1049–1053. 2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fernández-Sabé N, Rosón B, Carratalà J,
Dorca J, Manresa F and Gudiol F: Clinical diagnosis of Legionella
pneumonia revisited: Evaluation of the Community-Based Pneumonia
Incidence Study Group scoring system. Clin Infect Dis. 37:483–489.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Gupta SK and Sarosi GA: The role of
atypical pathogens in community-acquired pneumonia. Med Clin North
Am. 85:1349–1365, vii. 2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gramegna A, Sotgiu G, Di Pasquale M,
Radovanovic D, Terraneo S, Reyes LF, Vendrell E, Neves J, Menzella
F, Blasi F, et al: Atypical pathogens in hospitalized patients with
community-acquired pneumonia: A worldwide perspective. BMC Infect
Dis. 18(677)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cunha BA: Antibiotic pharmacokinetic
considerations in pulmonary infections. Semin Respir Infect.
6:168–182. 1991.PubMed/NCBI
|
|
16
|
Schüler P, Zemper K, Borner K, Koeppe P,
Schaberg T and Lode H: Penetration of sparfloxacin and
ciprofloxacin into alveolar macrophages, epithelial lining fluid,
and polymorphonuclear leucocytes. Eur Respir J. 10:1130–1136.
1997.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Honeybourne D: Antibiotic penetration in
the respiratory tract and implications for the selection of
antimicrobial therapy. Curr Opin Pulm Med. 3:170–174.
1997.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Muller-Serieys C, Soler P, Cantalloube C,
Lemaitre F, Gia HP, Brunner F and Andremont A: Bronchopulmonary
disposition of the ketolide telithromycin (HMR 3647). Antimicrob
Agents Chemother. 45:3104–3108. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Esposito S and Principi N: Asthma in
children: Are chlamydia or mycoplasma involved? Paediatr Drugs.
3:159–168. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Daian CM, Wolff AH and Bielory L: The role
of atypical organisms in asthma. Allergy Asthma Proc. 21:107–111.
2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
MacDowell AL and Bacharier LB: Infectious
triggers of asthma. Immunol Allergy Clin North Am. 25:45–66.
2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Micillo E, Bianco A, D'Auria D, Mazzarella
G and Abbate GF: Respiratory infections and asthma. Allergy. 55
(Suppl 61):S42–S45. 2000.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sessa R, Di Pietro M, Santino I, del Piano
M, Varveri A, Dagianti A and Penco M: Chlamydia pneumoniae
infection and atherosclerotic coronary disease. Am Heart J.
137:1116–1119. 1999.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ericson K, Saldeen TG, Lindquist O,
Pâhlson C and Mehta JL: Relationship of Chlamydia pneumoniae
infection to severity of human coronary atherosclerosis.
Circulation. 101:2568–2571. 2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zamorano J, García-Tejada J, Suárez A,
Culebras E, Castañón J, Moreno R, Reguillo F, Gil M, Picazo J and
Sánchez-Harguindey L: Chlamydia pneumoniae in the atherosclerotic
plaques of patients with unstable angina undergoing coronary artery
bypass grafting: Does it have prognostic implications? Int J
Cardiol. 90:297–302. 2003.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Weinberg AN: Respiratory infections
transmitted from animals. Infect Dis Clin North Am. 5:649–661.
1991.PubMed/NCBI
|
|
27
|
Gill V and Cunha BA: Tularemia pneumonia.
Semin Respir Infect. 12:61–67. 1997.PubMed/NCBI
|
|
28
|
Stubbs R, Dralle W and Williams J:
Psittacosis pneumonia. J Tenn Med Assoc. 82:189–190.
1989.PubMed/NCBI
|
|
29
|
Cotton EM, Strampfer MJ and Cunha BA:
Legionella and mycoplasma pneumonia-a community hospital experience
with atypical pneumonias. Clin Chest Med. 8:441–453.
1987.PubMed/NCBI
|
|
30
|
Arnold FW, Summersgill JT, Lajoie AS,
Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr,
Rello J, et al: A worldwide perspective of atypical pathogens in
community-acquired pneumonia. Am J Respir Crit Care Med.
175:1086–1093. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang S, Tang J, Tan Y, Song Z and Qin L:
Prevalence of atypical pathogens in patients with severe pneumonia:
A systematic review and meta-analysis. BMJ Open.
13(e066721)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cillóniz C, Ewig S, Polverino E, Marcos
MA, Esquinas C, Gabarrús A, Mensa J and Torres A: Microbial
aetiology of community-acquired pneumonia and its relation to
severity. Thorax. 66:340–346. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Capelastegui A, España PP, Bilbao A,
Gamazo J, Medel F, Salgado J, Gorostiaga I, Lopez de Goicoechea MJ,
Gorordo I, Esteban C, et al: Etiology of community-acquired
pneumonia in a population-based study: Link between etiology and
patients characteristics, process-of-care, clinical evolution and
outcomes. BMC Infect Dis. 12(134)2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Spoorenberg SM, Bos WJ, Heijligenberg R,
Voorn PG, Grutters JC, Rijkers GT and van de Garde EM: Microbial
aetiology, outcomes, and costs of hospitalisation for
community-acquired pneumonia; an observational analysis. BMC Infect
Dis. 14(335)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Van Gageldonk-Lafeber AB, Wever PC, van
der Lubben IM, de Jager CP, Meijer A, de Vries MC, Elberse K, van
der Sande MA and van der Hoek W: The aetiology of
community-acquired pneumonia and implications for patient
management. Neth J Med. 71:418–425. 2013.PubMed/NCBI
|
|
36
|
Shibli F, Chazan B, Nitzan O, Flatau E,
Edelstein H, Blondheim O, Raz R and Colodner R: Etiology of
community-acquired pneumonia in hospitalized patients in northern
Israel. Isr Med Assoc J. 12:477–482. 2010.PubMed/NCBI
|
|
37
|
Liu Y, Chen M, Zhao T, Wang H, Wang R, Cai
B, Cao B, Sun T, Hu Y, Xiu Q, et al: Causative agent distribution
and antibiotic therapy assessment among adult patients with
community acquired pneumonia in Chinese urban population. BMC
Infect Dis. 9(31)2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang
BQ, Li HY, Chen XH, Zhou CM and Deng WW: Etiology and antimicrobial
resistance of community-acquired pneumonia in adult patients in
China. Chin Med J (Engl). 125:2967–2972. 2012.PubMed/NCBI
|
|
39
|
Chen K, Jia R, Li L, Yang C and Shi Y: The
aetiology of community associated pneumonia in children in Nanjing,
China and aetiological patterns associated with age and season. BMC
Public Health. 15(113)2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Arancibia F, Cortes CP, Valdés M, Cerda J,
Hernández A, Soto L and Torres A: Importance of Legionella
pneumophila in the etiology of severe community-acquired pneumonia
in Santiago, Chile. Chest. 145:290–296. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Luchsinger V, Ruiz M, Zunino E, Martínez
MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, et
al: Community-acquired pneumonia in Chile: The clinical relevance
in the detection of viruses and atypical bacteria. Thorax.
68:1000–1006. 2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Vergis EN, Indorf A, File TM Jr, Phillips
J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J and YU VL:
Azithromycin vs cefuroxime plus erythromycin for empirical
treatment of community-acquired pneumonia in hospitalized patients:
A prospective, randomized, multicenter trial. Arch Intern Med.
160:1294–1300. 2000.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sopena N, Sabrià M, Pedro-Botet ML,
Manterola JM, Matas L, Domínguez J, Modol JM, Tudela P, Ausina V
and Foz M: Prospective study of community-acquired pneumonia of
bacterial etiology in adults. Eur J Clin Microbiol Infect Dis.
18:852–858. 1999.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Viasus D, Di Yacovo S, Garcia-Vidal C,
Verdaguer R, Manresa F, Dorca J, Gudiol F and Carratalà J:
Community-acquired Legionella pneumophila pneumonia: A
single-center experience with 214 hospitalized sporadic cases over
15 years. Medicine (Baltimore). 92:51–60. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Conklin L, Adjemian J, Loo J, Mandal S,
Davis C, Parks S, Parsons T, McDonough B, Partida J, Thurman K, et
al: Investigation of a Chlamydia pneumoniae outbreak in a Federal
correctional facility in Texas. Clin Infect Dis. 57:639–647.
2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Miyashita N, Fukano H, Okimoto N, Hara H,
Yoshida K, Niki Y and Matsushima T: Clinical presentation of
community-acquired Chlamydia pneumoniae pneumonia in adults. Chest.
121:1776–1781. 2002.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Puljiz I, Kuzman I, Dakovic-Rode O,
Schönwald N and Mise B: Chlamydia pneumoniae and Mycoplasma
pneumoniae pneumonia: Comparison of clinical, epidemiological
characteristics and laboratory profiles. Epidemiol Infect.
134:548–555. 2006.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yu Y and Fei A: Atypical pathogen
infection in community-acquired pneumonia. Biosci Trends. 10:7–13.
2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Reinton N, Manley L, Tjade T and Moghaddam
A: Respiratory tract infections during the 2011 Mycoplasma
pneumoniae epidemic. Eur J Clin Microbiol Infect Dis. 32:835–840.
2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Diaz MH and Winchell JM: The evolution of
advanced molecular diagnostics for the detection and
characterization of mycoplasma pneumoniae. Front Microbiol.
7(232)2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Brown RJ, Nguipdop-Djomo P, Zhao H,
Stanford E, Spiller OB and Chalker VJ: Mycoplasma pneumoniae
Epidemiology in England and Wales: A National Perspective. Front
Microbiol. 7(157)2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Narita M: Classification of extrapulmonary
manifestations due to mycoplasma pneumoniae infection on the basis
of possible pathogenesis. Front Microbiol. 7(23)2016.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Fraser DW, Tsai TR, Orenstein W, Parkin
WE, Beecham HJ, Sharrar RG, Harris J, Mallison GF, Martin SM,
McDade JE, et al: Legionnaires' disease: Description of an epidemic
of pneumonia. N Engl J Med. 297:1189–1197. 1977.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Glick TH, Gregg MB, Berman B, Mallison G,
Rhodes WW Jr and Kassanoff I: Pontiac fever. An epidemic of unknown
etiology in a health department: I. Clinical and epidemiologic
aspects. Am J Epidemiol. 107:149–160. 1978.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Levy I and Rubin LG: Legionella pneumonia
in neonates: A literature review. J Perinatol. 18:287–290.
1998.PubMed/NCBI
|
|
56
|
Garcia AV, Fingeret AL, Thirumoorthi AS,
Kadenhe-Chiweshe A and Kandel JJ: Severe Mycoplasma pneumoniae
infection requiring extracorporeal membrane oxygenation with
concomitant ischemic stroke in a child. Pediatr Pulmonol.
48:98–101. 2013.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Fisman DN, Lim S, Wellenius GA, Johnson C,
Britz P, Gaskins M, Maher J, Mittleman MA, Spain CV, Haas CN and
Newbern C: It's not the heat, it's the humidity: Wet weather
increases legionellosis risk in the greater Philadelphia
metropolitan area. J Infect Dis. 192:2066–2073. 2005.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Graham FF, White PS, Harte DJ and Kingham
SP: Changing epidemiological trends of legionellosis in New
Zealand, 1979-2009. Epidemiol Infect. 140:1481–1496.
2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Johnson DH and Cunha BA: Atypical
pneumonias. Clinical and extrapulmonary features of Chlamydia,
Mycoplasma, and Legionella infections. Postgrad Med. 93:69–72,
75-76, 79-82. 1993.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Sharma L, Losier A, Tolbert T, Dela Cruz
CS and Marion CR: Atypical Pneumonia: Updates on legionella,
chlamydophila, and mycoplasma pneumonia. Clin Chest Med. 38:45–58.
2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
McConnell CT Jr, Plouffe JF, File TM,
Mueller CF, Wong KH, Skelton SK, Marston BJ and Breiman RF:
Radiographic appearance of Chlamydia pneumoniae (TWAR strain)
respiratory infections. CBPIS Study Group. Community-based
Pneumonia Incidence Study. Radiology. 192:819–824. 1994.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Kauppinen MT, Lähde S and Syrjälä H:
Roentgenographic findings of pneumonia caused by Chlamydia
pneumoniae. A comparison with streptococcus pneumonia. Arch Intern
Med. 156:1851–1856. 1996.PubMed/NCBI
|
|
63
|
Boersma WG, Daniels JM, Löwenberg A, Boeve
WJ and van de Jagt EJ: Reliability of radiographic findings and the
relation to etiologic agents in community-acquired pneumonia.
Respir Med. 100:926–932. 2006.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Nambu A, Saito A, Araki T, Ozawa K,
Hiejima Y, Akao M, Ohki Z and Yamaguchi H: Chlamydia pneumoniae:
Comparison with findings of Mycoplasma pneumoniae and Streptococcus
pneumoniae at thin-section CT. Radiology. 238:330–338.
2006.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Gong L, Zhang CL and Zhen Q: Analysis of
clinical value of CT in the diagnosis of pediatric pneumonia and
mycoplasma pneumonia. Exp Ther Med. 11:1271–1274. 2016.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Mittal S, Singh A, Gold M, Leung AN,
Haramati LB and Katz DS: Thoracic imaging features of Legionnaire's
disease. Infect Dis Clin North Am. 31:43–54. 2017.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Evans AF, Oakley RH and Whitehouse GH:
Analysis of the chest radiograph in Legionnaires' disease. Clin
Radiol. 32:361–365. 1981.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Tan MJ, Tan JS, Hamor RH, File TM Jr and
Breiman RF: The radiologic manifestations of Legionnaire's disease.
The ohio community-based pneumonia incidence study group. Chest.
117:398–403. 2000.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Garg M, Prabhakar N, Gulati A, Agarwal R
and Dhooria S: Spectrum of imaging findings in pulmonary
infections. Part 1: Bacterial and viral. Pol J Radiol.
84:e205–e213. 2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Burillo A and Bouza E: Chlamydophila
pneumoniae. Infect Dis Clin North Am. 24:61–71. 2010.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Puolakkainen M: Laboratory diagnosis of
persistent human chlamydial infection. Front Cell Infect Microbiol.
3(99)2013.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Verkooyen RP, Willemse D, Hiep-van
Casteren SC, Joulandan SA, Snijder RJ, van den Bosch JM, van Helden
HP, Peeters MF and Verbrugh HA: Evaluation of PCR, culture, and
serology for diagnosis of Chlamydia pneumoniae respiratory
infections. J Clin Microbiol. 36:2301–2307. 1998.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Thurman KA, Warner AK, Cowart KC, Benitez
AJ and Winchell JM: Detection of Mycoplasma pneumoniae, Chlamydia
pneumoniae, and Legionella spp. in clinical specimens using a
single-tube multiplex real-time PCR assay. Diagn Microbiol Infect
Dis. 70:1–9. 2011.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Hammerschlag MR, Chirgwin K, Roblin PM,
Gelling M, Dumornay W, Mandel L, Smith P and Schachter J:
Persistent infection with Chlamydia pneumoniae following acute
respiratory illness. Clin Infect Dis. 14:178–182. 1992.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Jain S, Self WH, Wunderink RG, Fakhran S,
Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM,
et al: Community-Acquired Pneumonia Requiring Hospitalization among
U.S. Adults. N Engl J Med. 373:415–427. 2015.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Loens K and Ieven M: Mycoplasma
pneumoniae: Current knowledge on nucleic acid amplification
techniques and serological diagnostics. Front Microbiol.
7(448)2016.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Youn YS and Lee KY: Mycoplasma pneumoniae
pneumonia in children. Korean J Pediatr. 55:42–47. 2012.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Loens K, Ursi D, Goossens H and Ieven M:
Molecular diagnosis of Mycoplasma pneumoniae respiratory tract
infections. J Clin Microbiol. 41:4915–4923. 2003.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Herrera M, Aguilar YA, Rueda ZV, Muskus C
and Vélez LA: Comparison of serological methods with PCR-based
methods for the diagnosis of community-acquired pneumonia caused by
atypical bacteria. J Negat Results Biomed. 15(3)2016.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Loens K, Van Heirstraeten L,
Malhotra-Kumar S, Goossens H and Ieven M: Optimal sampling sites
and methods for detection of pathogens possibly causing
community-acquired lower respiratory tract infections. J Clin
Microbiol. 47:21–31. 2009.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Phin N, Parry-Ford F, Harrison T, Stagg
HR, Zhang N, Kumar K, Lortholary O, Zumla A and Abubakar I:
Epidemiology and clinical management of Legionnaires' disease.
Lancet Infect Dis. 14:1011–1021. 2014.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Avni T, Bieber A, Green H, Steinmetz T,
Leibovici L and Paul M: Diagnostic Accuracy of PCR Alone and
compared to urinary antigen testing for detection of legionella
spp: A systematic review. J Clin Microbiol. 54:401–411.
2016.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Nieuwenhuizen AA, Dijkstra F, Notermans DW
and van der Hoek W: Laboratory methods for case finding in human
psittacosis outbreaks: A systematic review. BMC Infect Dis.
18(442)2018.PubMed/NCBI View Article : Google Scholar
|
|
84
|
She RC, Thurber A, Hymas WC, Stevenson J,
Langer J, Litwin CM and Petti CA: Limited utility of culture for
Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of
respiratory tract infections. J Clin Microbiol. 48:3380–3382.
2010.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Hyman CL, Roblin PM, Gaydos CA, Quinn TC,
Schachter J and Hammerschlag MR: Prevalence of asymptomatic
nasopharyngeal carriage of Chlamydia pneumoniae in subjectively
healthy adults: Assessment by polymerase chain reaction-enzyme
immunoassay and culture. Clin Infect Dis. 20:1174–1178.
1995.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Kohlhoff SA and Hammerschlag MR: Treatment
of Chlamydial infections: 2014 update. Expert Opin Pharmacother.
16:205–212. 2015.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Roblin PM, Kohlhoff SA, Parker C and
Hammerschlag MR: In vitro activity of CEM-101, a new fluoroketolide
antibiotic, against Chlamydia trachomatis and Chlamydia
(Chlamydophila) pneumoniae. Antimicrob Agents Chemother.
54:1358–1359. 2010.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Chotikanatis K, Kohlhoff SA and
Hammerschlag MR: In vitro activity of nemonoxacin, a novel
nonfluorinated quinolone antibiotic, against Chlamydia trachomatis
and Chlamydia pneumoniae. Antimicrob Agents Chemother.
58:1800–1801. 2014.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Biedenbach DJ, Huband MD, Hackel M, de
Jonge BL, Sahm DF and Bradford PA: In vitro activity of AZD0914, a
novel bacterial DNA gyrase/topoisomerase IV inhibitor, against
clinically relevant gram-positive and fastidious gram-negative
pathogens. Antimicrob Agents Chemother. 59:6053–6063.
2015.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Van Rensburg DJ, Perng RP, Mitha IH,
Bester AJ, Kasumba J, Wu RG, Ho ML, Chang LW, Chung DT, Chang YT,
et al: Efficacy and safety of nemonoxacin versus levofloxacin for
community-acquired pneumonia. Antimicrob Agents Chemother.
54:4098–4106. 2010.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Liu Y, Zhang Y, Wu J, Zhu D, Sun S, Zhao
L, Wang X, Liu H, Ren Z, Wang C, et al: A randomized, double-blind,
multicenter Phase II study comparing the efficacy and safety of
oral nemonoxacin with oral levofloxacin in the treatment of
community-acquired pneumonia. J Microbiol Immunol Infect.
50:811–820. 2017.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Barrera CM, Mykietiuk A, Metev H, Nitu MF,
Karimjee N, Doreski PA, Mitha I, Tanaseanu CM, Molina JM,
Antonovsky Y, et al: Efficacy and safety of oral solithromycin
versus oral moxifloxacin for treatment of community-acquired
bacterial pneumonia: A global, double-blind, multicentre,
randomised, active-controlled, non-inferiority trial
(SOLITAIRE-ORAL). Lancet Infect Dis. 16:421–430. 2016.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Mandell LA, Wunderink RG, Anzueto A,
Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher
DM, Niederman MS, et al: Infectious Diseases Society of
America/American Thoracic Society consensus guidelines on the
management of community-acquired pneumonia in adults. Clin Infect
Dis. 44 (Suppl 2):S27–S72. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
94
|
Kashyap S and Sarkar M: Mycoplasma
pneumonia: Clinical features and management. Lung India. 27:75–85.
2010.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Cao B, Zhao CJ, Yin YD, Zhao F, Song SF,
Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H and Wang C: High
prevalence of macrolide resistance in Mycoplasma pneumoniae
isolates from adult and adolescent patients with respiratory tract
infection in China. Clin Infect Dis. 51:189–194. 2010.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Shimizu T: Inflammation-inducing Factors
of Mycoplasma pneumoniae. Front Microbiol. 7(414)2016.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Principi N and Esposito S: Emerging role
of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric
respiratory-tract infections. Lancet Infect Dis. 1:334–344.
2001.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Sánchez-Vargas FM and Gómez-Duarte OG:
Mycoplasma pneumoniae-an emerging extra-pulmonary pathogen. Clin
Microbiol Infect. 14:105–117. 2008.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Gacouin A, Le Tulzo Y, Lavoue S, Camus C,
Hoff J, Bassen R, Arvieux C, Heurtin C and Thomas R: Severe
pneumonia due to Legionella pneumophila: prognostic factors, impact
of delayed appropriate antimicrobial therapy. Intensive Care Med.
28:686–691. 2002.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Heath CH, Grove DI and Looke DF: Delay in
appropriate therapy of Legionella pneumonia associated with
increased mortality. Eur J Clin Microbiol Infect Dis. 15:286–290.
1996.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Edelstein PH: Legionnaires' disease. Clin
Infect Dis. 16:741–747. 1993.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Swanson DJ, Sung RJ, Fine MJ, Orloff JJ,
Chu SY and Yu VL: Erythromycin ototoxicity: Prospective assessment
with serum concentrations and audiograms in a study of patients
with pneumonia. Am J Med. 92:61–68. 1992.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Howden BP, Stuart RL, Tallis G, Bailey M
and Johnson PD: Treatment and outcome of 104 hospitalized patients
with legionnaires' disease. Intern Med J. 33:484–488.
2003.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Plouffe JF, Breiman RF, Fields BS, Herbert
M, Inverso J, Knirsch C, Kolokathis A, Marrie TJ, Nicolle L and
Schwartz DB: Azithromycin in the treatment of Legionella pneumonia
requiring hospitalization. Clin Infect Dis. 37:1475–1480.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
105
|
Dorrell L, Fulton B and Ong EL:
Intravenous azithromycin as salvage therapy in a patient with
Legionnaire's disease. Thorax. 49:620–621. 1994.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Sabrià M, Pedro-Botet ML, Gómez J, Roig J,
Vilaseca B, Sopena N and Baños V: Legionnaires Disease Therapy
Group. Fluoroquinolones vs macrolides in the treatment of
Legionnaires disease. Chest. 128:1401–1405. 2005.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Dunbar LM, Khashab MM, Kahn JB, Zadeikis
N, Xiang JX and Tennenberg AM: Efficacy of 750-mg, 5-day
levofloxacin in the treatment of community-acquired pneumonia
caused by atypical pathogens. Curr Med Res Opin. 20:555–563.
2004.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Burdet C, Lepeule R, Duval X, Caseris M,
Rioux C, Lucet JC and Yazdanpanah Y: Quinolones versus macrolides
in the treatment of legionellosis: A systematic review and
meta-analysis. J Antimicrob Chemother. 69:2354–2360.
2014.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Bruin JP, Koshkolda T, IJzerman EP, Lück
C, Diederen BM, Den Boer JW and Mouton JW: Isolation of
ciprofloxacin-resistant Legionella pneumophila in a patient with
severe pneumonia. J Antimicrob Chemother. 69:2869–2871.
2014.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Shadoud L, Almahmoud I, Jarraud S, Etienne
J, Larrat S, Schwebel C, Timsit JF, Schneider D and Maurin M:
Hidden Selection of Bacterial Resistance to Fluoroquinolones In
Vivo: The Case of Legionella pneumophila and Humans. EBioMedicine.
2:1179–1185. 2015.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Arnold FW, Summersgill JT and Ramirez JA:
Role of atypical pathogens in the etiology of community-acquired
pneumonia. Semin Respir Crit Care Med. 37:819–828. 2016.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Georgakopoulou VE, Lempesis IG, Sklapani
P, Trakas N and Spandidos DA: Exploring the pathogenetic mechanisms
of Mycoplasma pneumonia (Review). Exp Ther Med.
28(271)2024.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Waites KB, Xiao L, Liu Y, Balish MF and
Atkinson TP: Mycoplasma pneumoniae from the respiratory tract and
beyond. Clin Microbiol Rev. 30:747–809. 2017.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Liu KT, Yang KY, Lee YC and Perng RP: Risk
factor analysis of acute respiratory distress syndrome amoςινφng
hospitalized patients with Chlamydophila pneumoniae pneumonia. J
Chin Med Assoc. 70:318–323. 2007.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Wingfield T, Rowell S, Peel A, Puli D,
Guleri A and Sharma R: Legionella pneumonia cases over a five-year
period: A descriptive, retrospective study of outcomes in a UK
district hospital. Clin Med (Lond). 13:152–159. 2013.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Housset B: Rising to the challenge of
resistance: A case study-based discussion. Int J Antimicrob Agents.
29 (Suppl 1):S11–S16. 2007.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Cunningham AF, Johnston SL, Julious SA,
Lampe FC and Ward ME: Chronic Chlamydia pneumoniae infection and
asthma exacerbations in children. Eur Respir J. 11:345–349.
1998.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Von Hertzen L, Töyrylä M, Gimishanov A,
Bloigu A, Leinonen M, Saikku P and Haahtela T: Asthma, atopy and
Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy.
29:522–528. 1999.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Koyi H, Brandén E, Gnarpe J, Gnarpe H and
Steen B: An association between chronic infection with Chlamydia
pneumoniae and lung cancer. A prospective 2-year study. APMIS.
109:572–580. 2001.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Kocazeybek B: Chronic Chlamydophila
pneumoniae infection in lung cancer, a risk factor: A case-control
study. J Med Microbiol. 52:721–726. 2003.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Littman AJ, White E, Jackson LA,
Thornquist MD, Gaydos CA, Goodman GE and Vaughan TL: Chlamydia
pneumoniae infection and risk of lung cancer. Cancer Epidemiol
Biomarkers Prev. 13:1624–1630. 2004.PubMed/NCBI
|
|
122
|
Koh WP, Chow VT, Phoon MC, Ramachandran N
and Seow A: Lack of association between chronic Chlamydophila
pneumoniae infection and lung cancer among nonsmoking Chinese women
in Singapore. Int J Cancer. 114:502–504. 2005.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Xue L, Liang YH, Gao YY and Wang XJ:
Clinical study of chlamydia pneumoniae infection in patients with
coronary heart disease. BMC Cardiovasc Disord.
19(110)2019.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Dogra J: Oral azithromycin in extended
dosage schedule for chronic, subclinical Chlamydia pneumoniae
infection causing coronary artery disease: A probable cure in
sight? Results of a controlled preliminary trial. Int J Gen Med.
5:505–509. 2012.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Su X and Chen HL: Chlamydia pneumoniae
infection and cerebral infarction risk: A meta-analysis. Int J
Stroke. 9:356–364. 2014.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Huong Ple T, Hien PT, Lan NT, Binh TQ,
Tuan DM and Anh DD: First report on prevalence and risk factors of
severe atypical pneumonia in Vietnamese children aged 1-15 years.
BMC Public Health. 14(1304)2014.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Morozumi M, Iwata S, Hasegawa K, Chiba N,
Takayanagi R, Matsubara K, Nakayama E, Sunakawa K and Ubukata K:
Acute Respiratory Diseases Study Group. Increased macrolide
resistance of Mycoplasma pneumoniae in pediatric patients with
community-acquired pneumonia. Antimicrob Agents Chemother.
52:348–350. 2008.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Dumke R, von Baum H, Lück PC and Jacobs E:
Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in
Germany. Clin Microbiol Infect. 16:613–616. 2010.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Peuchant O, Ménard A, Renaudin H, Morozumi
M, Ubukata K, Bébéar CM and Pereyre S: Increased macrolide
resistance of Mycoplasma pneumoniae in France directly detected in
clinical specimens by real-time PCR and melting curve analysis. J
Antimicrob Chemother. 64:52–58. 2009.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Principi N and Esposito S:
Macrolide-resistant Mycoplasma pneumoniae: Its role in respiratory
infection. J Antimicrob Chemother. 68:506–511. 2013.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z
and Chen Z: More complications occur in macrolide-resistant than in
macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob
Agents Chemother. 58:1034–1038. 2014.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Gautam J and Krawiec C: Chlamydia
Pneumonia. StatPearls Publishing, Treasure Island, FL, 2024.
Available from: https://www.ncbi.nlm.nih.gov/books/NBK560874/.
|
|
133
|
Marchese S, Marchese G, Paviglianiti G,
Lapi M, Ottoveggio G, Pipitone G and Corsello G: A pediatric case
of Chlamydia psittaci caused severe Acute Respiratory Distress
Syndrome (ARDS) in Italy. Ital J Pediatr. 49(107)2023.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Hashimoto K, Nishimura S and Akagi M: Lung
adenocarcinoma presenting as a soft tissue metastasis to the
shoulder: A case report. Medicina (Kaunas). 57(181)2021.PubMed/NCBI View Article : Google Scholar
|
